E-drug: AIDS and Africa
---------------------------------------------
FOREIGN POLICY IN FOCUS
http://fpif.org/index.html
--------------------------------------------------------------
Dear Colleagues,
The following policy brief has been updated in response to the March
5th actions taking place around the world in support of South Africa's
Treatment Action campaign. The analysis identifies the role of the U.S.
government in developing and patenting HIV/AIDS drugs and explains
the policy measure that can and should be taken by the U.S. government
to alleviate the AIDS pandemic.
This 4-page brief is downloadable for free in .pdf format and can be
reproduced without permission in the event that organizors, activists
and health officials find it to be a useful tool in their advocacy
and outreach work.
Best regards,
Tim McGivern
Foreign Policy In Focus
AIDS and Developing Countries: Facilitating Access to Essential Medicines
Volume 6, Number 6
March 2001
By Robert Weissman
http://fpif.org/briefs/vol6/v6n06aids.html
"The U.S. should immediately license all HIV/AIDS drugs that have been
developed and patented with government funding to the World Health
Organization. Existing law permits Washington to take such steps. With a
license, the WHO could contract with private generic makers to
produce the medicines and distribute them widely in the developing
world. Since many of the most important HIV/AIDS remedies-such as
ddI-were developed with significant U.S. government funding, the U.S.
government controls rights to many important HIV/AIDS treatment
pharmaceuticals.
For a complete listing of FPIF materials covering U.S. foreign policy
toward Africa visit:
http://fpif.org/indices/regions/africa.html
--------------------------------------------------------------
FOREIGN POLICY IN FOCUS
http://fpif.org/index.html
--------------------------------------------------------------
Interhemispheric Resource Center/Institute for Policy Studies
Foreign Policy In Focus Program
Box 4506
Albuquerque, NM 87196
infocus@fpif.org
505-246-1601 (fax)
ircalb@swcp.com
733 15th St. ste. 1020
Washington, DC 20005
202-234-9382, ext 240
ipsps@igc.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.